» Articles » PMID: 28387228

Calcium Oxalate Crystals and Oxalate Induce an Epithelial-to-mesenchymal Transition in the Proximal Tubular Epithelial Cells: Contribution to Oxalate Kidney Injury

Overview
Journal Sci Rep
Specialty Science
Date 2017 Apr 8
PMID 28387228
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

TGF-β1 is the main mediator of epithelial-to-mesenchymal transition (EMT). Hyperoxaluria induces crystalluria, interstitial fibrosis, and progressive renal failure. This study analyzed whether hyperoxaluria is associated with TGF-β1 production and kidney fibrosis in mice and if oxalate or calcium oxalate (CaOx) could induce EMT in proximal tubule cells (HK2) and therefore contribute to the fibrotic process. Hyperoxaluria was induced by adding hydroxyproline and ethylene glycol to the mice's drinking water for up to 60 days. Renal function and oxalate and urinary crystals were evaluated. Kidney collagen production and TGF-β1 expression were assessed. EMT was analyzed in vitro according to TGF-β1 production, phenotypic characterization, invasion, cell migration, gene and protein expression of epithelial and mesenchymal markers. Hyperoxaluric mice showed a decrease in renal function and an increase in CaOx crystals and Ox urinary excretion. The deposition of collagen in the renal interstitium was observed. HK2 cells stimulated with Ox and CaOx exhibited a decreased expression of epithelial as well as increased expression mesenchymal markers; these cells presented mesenchymal phenotypic changes, migration, invasiveness capability and TGF-β1 production, characterizing EMT. Treatment with BMP-7 or its overexpression in HK2 cells was effective at preventing it. This mechanism may contribute to the fibrosis observed in hyperoxaluria.

Citing Articles

Comparison of Endoplasmic Reticulum Stress and Pyroptosis Induced by Pathogenic Calcium Oxalate Monohydrate and Physiologic Calcium Oxalate Dihydrate Crystals in HK-2 Cells: Insights into Kidney Stone Formation.

Nong W, Tong X, Ouyang J Cells. 2025; 13(24.

PMID: 39768161 PMC: 11674083. DOI: 10.3390/cells13242070.


Plasma metabolomics reveals risk factors for lung adenocarcinoma.

Yu M, Wen W, Wang Y, Shan X, Yi X, Zhu W Front Oncol. 2024; 14:1277206.

PMID: 38567154 PMC: 10985191. DOI: 10.3389/fonc.2024.1277206.


Management of nephrolithiasis after kidney transplantation: a comprehensive review from the European Renal Association CKD-MBD working group.

Kanbay M, Copur S, Bakir C, Hatipoglu A, Sinha S, Haarhaus M Clin Kidney J. 2024; 17(2):sfae023.

PMID: 38410685 PMC: 10896178. DOI: 10.1093/ckj/sfae023.


The Nephroprotective Effects of the Allogeneic Transplantation with Mesenchymal Stromal Cells Were Potentiated by ω3 Stimulating Up-Regulation of the PPAR-γ.

de Oliveira A, Convento M, Razvickas C, Castino B, Leme A, da Silva Luiz R Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895955 PMC: 10610511. DOI: 10.3390/ph16101484.


Oxalate (dys)Metabolism: Person-to-Person Variability, Kidney and Cardiometabolic Toxicity.

Baltazar P, de Melo Junior A, Fonseca N, Lanca M, Faria A, Sequeira C Genes (Basel). 2023; 14(9).

PMID: 37761859 PMC: 10530622. DOI: 10.3390/genes14091719.


References
1.
Hay E . An overview of epithelio-mesenchymal transformation. Acta Anat (Basel). 1995; 154(1):8-20. DOI: 10.1159/000147748. View

2.
Zeisberg M, Kalluri R . The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med (Berl). 2004; 82(3):175-81. DOI: 10.1007/s00109-003-0517-9. View

3.
Loeffler I, Wolf G . Transforming growth factor-β and the progression of renal disease. Nephrol Dial Transplant. 2013; 29 Suppl 1:i37-i45. DOI: 10.1093/ndt/gft267. View

4.
Fukuda N, Tahira Y, Matsuda H, Matsumoto K . Transforming growth factor-beta as a treatment target in renal diseases. J Nephrol. 2009; 22(6):708-15. View

5.
Miyazono K . Positive and negative regulation of TGF-beta signaling. J Cell Sci. 2000; 113 ( Pt 7):1101-9. DOI: 10.1242/jcs.113.7.1101. View